KAMADA » INVESTORS » NEWS & EVENTS

NEWS & EVENTS

Latest News

Kamada Reports 2017 First Quarter Financial Results

May. 17, 2017

Reaffirms revenue guidance of $100 million for 2017
Proprietary Products segment for 2017 projected at $76-$78 million, up at least 36% compared to
2016.

Kamada to Host First Quarter 2017 Financial Results Conference Call on May 16

May. 16, 2017

Link to webcast

Kamada management will host an investment community conference call on Tuesday, May 16 at 8:30am Eastern Time to discuss these results and answer questions.


Upcoming Events

Kamada to participate in ATS conference, Washington DC, 2017

May. 19-24, 2017 / Washington DC, USA

The American Thoracic Society improves global health by advancing research, patient care, and public health in pulmonary disease, critical illness, and sleep disorders. Founded in 1905 to combat TB, the ATS has grown to tackle asthma, COPD, lung cancer, sepsis, acute respiratory distress, and sleep apnea, among other diseases.

Kamada to participate in Jefferies 2017 Global Healthcare Conference

Jun. 6-9, 2017 / New York, NY

The Jefferies 2017 Global Healthcare conference will feature an extensive range of public & private healthcare companies across the Biopharmaceuticals, Life Sciences, Healthcare Services, Healthcare IT and Medical Technology sectors. This global gathering of leading executives, institutional investors, private equity investors and VCs will address near- and long-term investment opportunities and discuss the mechanisms driving healthcare in the U.S. and internationally.


Past Event

Kamada to participate in 15th Conference of the International Society of Travel Medicine

May. 14-18, 2017 / Barcelona - Spain

the 15th Conference of the International Society of Travel Medicine (CISTM15) on 14-18 May 2017 in Barcelona, Spain, marks a highlight in the history of the International Society of Travel Medicine as it will celebrate its 25th anniversary. the International Society of Travel Medicine have 35,000 members from more than 90 countries.